BMRN vs O · P/E 40, rev $2.85B vs P/E 50, rev $5.27B
Biomarin Pharmaceutical Inc (BMRN) versus Realty Income Corporation (O) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Realty Income Corporation (O) is a reit - retail company listed on NYSE.
Latest reported BMRN revenue for 2024-12-31 was $2.85B. Net income was $426.9M. Revenue was up 18.0% from 2023-12-31 to 2024-12-31. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported O revenue for 2024-12-31 was $5.27B. Net income was $867.3M. Revenue was up 29.2% from 2023-12-31 to 2024-12-31. O currently screens at market cap $56.48B and trailing P/E 49.6.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. O currently screens at market cap $56.48B and trailing P/E 49.6.
Not investment advice. Open the BMRN and O stock pages for the full models.
Not investment advice.